{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:41:36Z","timestamp":1792395696763,"version":"4.4.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Primary bone lymphomas are rare, and most reported cases represent diffuse large B-cell lymphoma. Low-grade B-cell lymphomas presenting with primary osseous involvement (PB-LGBCLs) are far less common, and their clinicopathologic features and clinical course remain poorly defined. We retrospectively analyzed 32 PB-LGBCLs diagnosed at a single tertiary cancer center. Cases were included when the disease presented with bone-only involvement, with or without contiguous soft tissue extension, and without lymph node, spleen, or noncontiguous extranodal disease at initial diagnosis. Staging marrow and low-level peripheral blood involvement were recorded but were not used as exclusion criteria. The cohort included follicular lymphoma (FL; 22\/32, 69%), marginal zone lymphoma (MZL; 6\/32, 19%), lymphoplasmacytic lymphoma (LPL; 2\/32, 6%), and chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL; 2\/32, 6%). Median age was 64 years (range: 39 to 87), and 25\/32 patients (78%) had multifocal skeletal disease, most often involving the pelvis and spine. Primary bone FL frequently showed features typical of conventional FL, including germinal center B-cell phenotype, frequent BCL2 rearrangement, and recurrent FL-associated mutations. Non-FL subtypes showed clinicopathologic features and molecular findings compatible with their systemic counterparts. Among 27 patients with more than 6 months of follow-up, disease progression or transformation occurred in 12 patients. Three FLs transformed to diffuse large B-cell lymphoma. No deaths occurred. PB-LGBCLs are rare with FL as the most common subtype and show heterogeneous biology and clinical behavior. Recognition of this presentation is important to avoid misclassification as aggressive lymphoma, nonhematolymphoid bone neoplasm, or reactive condition.<\/jats:p>","DOI":"10.1097\/pas.0000000000002631","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:00:23Z","timestamp":1792393223000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pathology, Clinical Features, and Natural History of Low-Grade B-Cell Lymphomas With Primary Osseous Presentation"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0751-0615","authenticated-orcid":false,"given":"Shenon","family":"Sethi","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Hematopathology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Isgor","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Hematopathology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi K.","family":"Galera","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Hematopathology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Luttwak","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lymphoma Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Sch\u00f6der","sequence":"additional","affiliation":[{"name":"Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles A.","family":"Salles","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lymphoma Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Hematopathology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"R2-20261019","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ctrv.2015.02.001","article-title":"Primary and secondary bone lymphomas","volume":"41","author":"Messina","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"R3-20261019","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/cncr.21930","article-title":"Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients","volume":"106","author":"Beal","year":"2006","journal-title":"Cancer"},{"key":"R4-20261019","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/PAS.0b013e3181b314ce","article-title":"Primary bone diffuse large B-cell lymphoma: clinicopathologic study of 21 cases and review of literature","volume":"33","author":"Bhagavathi","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R5-20261019","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3109\/10428194.2013.853298","article-title":"The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study)","volume":"55","author":"Govi","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"R6-20261019","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/cncr.24828","article-title":"Primary lymphoma of bone in adult patients","volume":"116","author":"Jawad","year":"2010","journal-title":"Cancer"},{"key":"R7-20261019","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdl329","article-title":"A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency","volume":"18","author":"Ramadan","year":"2007","journal-title":"Ann Oncol"},{"key":"R8-20261019","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1002\/cpz1.884","article-title":"19-color, 21-Antigen Single Tube for Efficient Evaluation of B- and T-cell Neoplasms","volume":"3","author":"Chan","year":"2023","journal-title":"Curr Protoc"},{"key":"R9-20261019","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41408-024-01148-x","article-title":"Limited stage high grade B-cell lymphoma with MYC, BCL2 and\/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes","volume":"14","author":"Lue","year":"2024","journal-title":"Blood Cancer J"},{"key":"R10-20261019","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1038\/s41467-023-42585-9","article-title":"Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing","volume":"14","author":"Ptashkin","year":"2023","journal-title":"Nat Commun"},{"key":"R11-20261019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/aol-20-38","article-title":"Biology of splenic and nodal marginal zone lymphomas","volume":"5","author":"Spina","year":"2021","journal-title":"Ann Lymphoma"},{"key":"R12-20261019","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1182\/blood.2024025794","article-title":"EMZL at various sites: learning from each other","volume":"145","author":"Du","year":"2025","journal-title":"Blood"},{"key":"R13-20261019","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.2021012386","article-title":"Genetic and phenotypic attributes of splenic marginal zone lymphoma","volume":"139","author":"Bonfiglio","year":"2022","journal-title":"Blood"},{"key":"R14-20261019","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1182\/blood-2008-08-174110","article-title":"The NF-kappaB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas","volume":"113","author":"Novak","year":"2009","journal-title":"Blood"},{"key":"R15-20261019","first-page":"280","article-title":"Primary bone lymphoma: experience with 52 patients","volume":"88","author":"Zinzani","year":"2003","journal-title":"Haematologica"},{"key":"R16-20261019","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10428190903308007","article-title":"Primary bone lymphoma--the University of Miami experience","volume":"51","author":"Alencar","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"R17-20261019","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijrobp.2011.06.1976","article-title":"Early-Stage Primary Bone Lymphoma: A Retrospective, Multicenter Rare Cancer Network (RCN) Study","volume":"83","author":"Cai","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-20261019","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"key":"R21-20261019","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"key":"R22-20261019","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2559.2007.02678.x","article-title":"Significant high expression of CD23 in follicular lymphoma of the inguinal region","volume":"50","author":"Thorns","year":"2007","journal-title":"Histopathology"},{"key":"R23-20261019","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/PAS.0b013e31817d7470","article-title":"Follicular lymphoma of the thyroid gland","volume":"33","author":"Bacon","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R24-20261019","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/PAS.0b013e31822bd8a8","article-title":"Clinicopathologic and Genetic Characterization of Follicular Lymphomas Presenting in the Ovary Reveals 2 Distinct Subgroups","volume":"35","author":"\u00d6zsan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R25-20261019","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PAS.0000000000002003","article-title":"Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL)","volume":"47","author":"Saksena","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R26-20261019","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1182\/bloodadvances.2022009456","article-title":"The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas","volume":"7","author":"Salaverria","year":"2023","journal-title":"Blood Adv"},{"key":"R27-20261019","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/PAS.0b013e31802ee4ab","article-title":"Primary follicular lymphoma of the testis and epididymis in adults","volume":"31","author":"Bacon","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R28-20261019","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","article-title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","volume":"132","author":"Hellmuth","year":"2018","journal-title":"Blood"},{"key":"R29-20261019","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaophthalmol.2014.376","article-title":"Ocular Adnexal Follicular Lymphoma","volume":"132","author":"Rasmussen","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R30-20261019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-022-03421-5","article-title":"Recent advances in cutaneous lymphoma\u2014implications for current and future classifications","volume":"482","author":"Goodlad","year":"2023","journal-title":"Virchows Arch"},{"key":"R31-20261019","doi-asserted-by":"crossref","first-page":"100440","DOI":"10.1016\/j.modpat.2024.100440","article-title":"Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases","volume":"37","author":"Sarro","year":"2024","journal-title":"Mod Pathol"},{"key":"R32-20261019","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.leu.2403844","article-title":"Clonal selection in the bone marrow involvement of follicular lymphoma","volume":"19","author":"Bognar","year":"2005","journal-title":"Leukemia"},{"key":"R33-20261019","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/imr.12745","article-title":"Molecular pathogenesis of germinal center-derived B cell lymphomas","volume":"288","author":"Pasqualucci","year":"2019","journal-title":"Immunol Rev"},{"key":"R34-20261019","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood.2023021000","article-title":"Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm","volume":"143","author":"Laurent","year":"2024","journal-title":"Blood"},{"key":"R35-20261019","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/his.15096","article-title":"Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis","volume":"84","author":"Ivanova","year":"2024","journal-title":"Histopathology"},{"key":"R36-20261019","first-page":"3760","article-title":"Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype","volume":"5","author":"de Groen","year":"2021","journal-title":"Blood Adv"},{"key":"R37-20261019","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/00000478-200309000-00011","article-title":"Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation","volume":"27","author":"de Leval","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R38-20261019","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/modpathol.3880425","article-title":"An immunophenotypic and molecular study of primary large B-cell lymphoma of bone","volume":"14","author":"Huebner-Chan","year":"2001","journal-title":"Mod Pathol"},{"key":"R39-20261019","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/PAS.0000000000000923","article-title":"Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center","volume":"41","author":"Li","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R40-20261019","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1309\/CMPGPYTMFRM6RVQR","article-title":"Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene","volume":"129","author":"Lima","year":"2008","journal-title":"Am J Clin Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:00:27Z","timestamp":1792393227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002631","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]}}}